5 (532) · $ 23.50 · In stock
Researchers at the Sanford Burnham Prebys Medical Discovery Institute (SBP) reported new findings this week that may lead to novel therapeutic strategies for people suffering from Duchenne muscular dystrophy (DMD). DMD, a muscle-wasting disease that affects 1 in 7250 males aged 5 to 24 years in the United States, is caused by a genetic mutation leading…
Frontiers Current Pharmacological Strategies for Duchenne Muscular Dystrophy
Dystrophin The Stem Cellar
Cardiovascular Disease in Duchenne Muscular Dystrophy: Overview and Insight Into Novel Therapeutic Targets - ScienceDirect
Closing in on a cure for Duchenne muscular dystrophy, Brain, Discovery
Unusually severe muscular dystrophy upon in-frame deletion of the
Therapeutic approaches for Duchenne muscular dystrophy
Frontiers Duchenne muscular dystrophy: disease mechanism and therapeutic strategies
Sanford Burnham Prebys Medical Discovery Institute
Muscular Dystrophy
De novo revertant fiber formation and therapy testing in a 3D culture model of Duchenne muscular dystrophy skeletal muscle - ScienceDirect
muscle stem cells, The Stem Cellar
Nutrients, Free Full-Text
Frontiers Current Pharmacological Strategies for Duchenne Muscular Dystrophy